Shuren At FDLI: Least-Burdensome, Real-World Evidence Efforts Picking Up

US FDA's device-center head discussed his continued push to make regulations more flexible, plans for least-burdensome training and what's next for NEST, among other topics, at the Food & Drug Law Institute annual gathering in Washington DC.